Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx

被引:0
|
作者
R. Böscke
B. D. Cakir
A. S. Hoffmann
S. Wiegand
J. Quetz
J. E. Meyer
机构
[1] University Medical Center Schleswig–Holstein,Department of Otorhinolaryngology, Head and Neck Surgery, Campus Lübeck
[2] Universität zu Lübeck,Department of Otorhinolaryngology, Head and Neck Surgery
[3] University Hospital Giessen & Marburg,Department of Otorhinolaryngology, Head and Neck Surgery, Campus Kiel
[4] University Medical Center Schleswig–Holstein,Department of Otorhinolaryngology, Head and Neck Surgery
[5] Christian-Albrechts-Universität zu Kiel,Asklepios Medical School, Campus Hamburg
[6] Asklepios Klinik St. Georg,undefined
[7] Semmelweis University,undefined
关键词
Elective neck dissection; N0 neck; Observation; Wait-and-see; Oropharynx; Oropharyngeal cancer;
D O I
暂无
中图分类号
学科分类号
摘要
Optimal elective neck treatment in node-negative (cN0) oropharyngeal squamous cell carcinoma (OPSCC) patients is still controversially discussed. Retrospective chart review of 49 cT1-3 cN0 cM0 OPSCC patients, who had undergone surgical resection of the primary and either elective neck dissection (END) (n = 32) or observation (OBS) (n = 17) of the neck was performed. For systematic review of literature, Pubmed and EMBASE were searched for clinical studies including data on both END and OBS of the neck in cN0 OPSCC patients. Estimated 5-year overall survival (OS) rate was 82 % for END and 76 % for OBS [hazard ratio (HR) = 1.01]. Estimated 5-year disease-free survival (DFS) rate was 78 % for END and 67 % for OBS (HR = 1.79); 5-year DSS rate was 97 % (END) and 81 % (OBS) (HR = 2.22). None of the primary outcome variables (OS, DFS, DSS) revealed statistically significant effects for the treatment assignments. Hazard ratios implied an advantage for END. Systematic review of literature yielded only retrospective chart reviews and no data meeting our selection criteria for further data analysis. Due to lack of high-level evidence, the decision for END in cN0 OPSCC remains a diagnostic and therapeutic challenge. The demonstrated clinical equipoise would provide a solid basis for a multicentric, randomized trial.
引用
收藏
页码:567 / 574
页数:7
相关论文
共 50 条
  • [31] Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study
    Zirong Huo
    Shuiting Fu
    Chunyue Ma
    Surui Sheng
    [J]. BMC Cancer, 22
  • [32] Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study
    Huo, Zirong
    Fu, Shuiting
    Ma, Chunyue
    Sheng, Surui
    [J]. BMC CANCER, 2022, 22 (01)
  • [33] Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: Elective neck dissection versus observation
    Lim, YC
    Lee, JS
    Koo, BS
    Kim, SH
    Kim, YH
    Choi, EC
    [J]. LARYNGOSCOPE, 2006, 116 (03): : 461 - 465
  • [34] Primary Treatment Selection for Clinically Node-Negative Merkel Cell Carcinoma of the Head and Neck
    Jacobs, Daniel
    Olino, Kelly
    Park, Henry S.
    Clune, James
    Cheraghlou, Shayan
    Girardi, Michael
    Burtness, Barbara
    Kluger, Harriet
    Judson, Benjamin L.
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 164 (06) : 1214 - 1221
  • [35] The role of elective supraomohyoidal neck dissection in the treatment of early, node-negative oral squamous cell carcinoma (OSCC): A retrospective analysis of 122 cases
    Thiele, Oliver C.
    Seeberger, Robin
    Flechtenmacher, Christa
    Hofele, Christof
    Freier, Kolja
    [J]. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2012, 40 (01) : 67 - 70
  • [36] Elective neck dissection and survival in patients with squamous cell carcinoma of the oral cavity and oropharynx
    Duvvuri, U
    Simental, AA
    D'Angelo, G
    Johnson, JT
    Ferris, RL
    Gooding, W
    Myers, EN
    [J]. LARYNGOSCOPE, 2004, 114 (12): : 2228 - 2234
  • [37] Preservation of level IIb lymph nodes during supraomohyoid neck dissection for clinically node-negative oral squamous cell carcinoma
    Wu, Hao
    Sun, Xue-Hui
    Hu, Wen Ting
    Zhang, Ling
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (12): : 8030 - 8039
  • [38] Lymphoscintigraphy Concordance with Intraoperative Findings from Sentinel Lymph Node (SLN) Biopsy with [99mTc] Tilmanocept in Clinically Node-negative (cN0) Head and Neck Squamous Cell Carcinoma Patients (HNSCC)
    Chepeha, D.
    Agrawal, A.
    Civantos, F. J.
    Lai, S. Y.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S31 - S31
  • [40] Protocol for a multicentre, prospective observational study of elective neck dissection for clinically node-negative oral tongue squamous cell carcinoma (END-TC study)
    Yanamoto, Souichi
    Michi, Yasuyuki
    Otsuru, Mitsunobu
    Inomata, Toru
    Nakayama, Hideki
    Nomura, Takeshi
    Hasegawa, Takumi
    Yamamura, Yoshiko
    Yamada, Shin-ichi
    Kusukawa, Jingo
    Yamakawa, Nobuhiro
    Hasegawa, On
    Ueda, Michihiro
    Kitagawa, Yoshimasa
    Hiraki, Akimitsu
    Hasegawa, Toshihiro
    Ohiro, Yoichi
    Kobayashi, Wataru
    Asoda, Seiji
    Kobayashi, Takanori
    Iino, Mitsuyoshi
    Fukuda, Masayuki
    Ishibashi-Kanno, Naomi
    Kawaguchi, Koji
    Aijima, Reona
    Noguchi, Kazuma
    Okura, Masaya
    Tanaka, Akira
    Sugiura, Tsuyoshi
    Shintani, Yukari
    Yagihara, Kazuhiro
    Yamashiro, Masashi
    Ota, Yoshihide
    Miyazaki, Akihiro
    Takeshita, Akinori
    Kawamata, Hitoshi
    Hiroshi, Iwabuchi
    Uchida, Kenichiro
    Umeda, Masahiro
    Kurita, Hiroshi
    Kirita, Tadaaki
    [J]. BMJ OPEN, 2022, 12 (09):